Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.
Aljumah
A A
AA
Liver Transplant Program, Toronto Hospital, University of Toronto, Canada.
Cattral
M S
MS
Greig
P D
PD
Wanless
I R
IR
Krajden
M
M
Hemming
A W
AW
Lilly
L B
LB
Levy
G A
GA
D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D008111:Liver Function Tests; D016031:Liver Transplantation; D011183:Postoperative Complications; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D013997:Time Factors
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin